Andromeda Metals Limited (ASX:ADN) has lodged an Appendix 2A application for the quotation of 308,573 options expiring 11 December 2027 (ASX code: ADNOD), issued on 20 November 2026 as free-attaching options to shares subscribed for under the company's 2025 Share Purchase Plan.
Key Points
- 308,573 options with the ASX code ADNOD, expiring 11 December 2027, applied for quotation with an issue date of 20 November 2026.
- The options were issued to Sue-Ann Higgins as free-attaching options in relation to shares subscribed for under the 2025 Share Purchase Plan at $0.0175 per share.
- Shareholder approval for the issue was granted at the company's AGM held on 19 November 2026.
- Following quotation, the total ADNOD class on issue will be 493,754,396 options.
Terms of the Free-Attaching Option Issue
According to the filing, the 308,573 options are being issued for no cash consideration, with the stated consideration described as free-attaching options for shares issued at $0.0175 under the 2025 Share Purchase Plan. The estimated value of consideration per security is recorded as $0.000000. The options carry the ASX security code ADNOD and are set to expire on 11 December 2027. The filing states that the securities were issued as part of a transaction previously announced to the market via an Appendix 3B dated 17 October 2025, and that no further issues of securities remain to complete that transaction.
Shareholder Approval and Recipient Details
The filing discloses that the options were issued to Sue-Ann Higgins in relation to shares she subscribed for under the 2025 Share Purchase Plan. Approval for the issue was granted by shareholders at the company's Annual General Meeting held on 19 November 2026, one day prior to the issue date of 20 November 2026. The original proposed issue of securities was notified to ASX under a New Announcement Appendix 3B titled "New - Proposed issue of securities - ADN," lodged on 17 October 2025 at 09:10.
Issued Capital Following Quotation
Following the quotation of the 308,573 ADNOD options, Andromeda Metals' quoted securities will comprise 5,141,840,313 ordinary fully paid shares (ASX:ADN), 293,461,554 options expiring 2 July 2027 (ADNO), 338,378,131 options expiring 30 September 2027 (ADNOC), and 493,754,396 options expiring 11 December 2027 (ADNOD). The company's unquoted securities include 21,461,600 performance rights (ADNAB), 35,612,144 options expiring 2 December 2027 at nil exercise price (ADNAC), and 24,794,118 options expiring on various dates at various prices (ADNAA).



Please wait processing your request...